The "TPM1 Gene Cardiomyopathy Dilated Type 1Y Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the TPM1 gene, which are associated with dilated cardiomyopathy type 1Y (DCM1Y). Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's ventricles, leading to impaired blood pumping efficiency. The TPM1 gene encodes for a protein that plays a crucial role in the contraction of heart muscle fibers, and mutations in this gene can disrupt heart function, contributing to the development of DCM1Y.
This genetic test is crucial for individuals with a family history of dilated cardiomyopathy or those presenting symptoms suggestive of the condition, as it can provide a definitive diagnosis of DCM1Y. Early identification of the genetic mutation allows for timely intervention, personalized treatment plans, and the opportunity for family members to be screened for the same genetic predisposition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and reliability in results. The cost of the TPM1 Gene Cardiomyopathy Dilated Type 1Y Genetic Test is 4400 AED, reflecting the advanced technology and expertise required to conduct this specialized genetic analysis. By opting for this test, patients and healthcare providers can make informed decisions regarding the management of dilated cardiomyopathy and take proactive steps towards heart health.
The "TNNC1 Gene Cardiomyopathy Dilated Type 1Z Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the TNNC1 gene that are associated with Dilated Cardiomyopathy (DCM) type 1Z. This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to an enlarged and weakened heart muscle. The TNNC1 gene plays a critical role in the heart's muscle contraction mechanism, and mutations in this gene can disrupt normal heart function, contributing to the development of DCM.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the TNNC1 gene. Identifying these mutations can be crucial for the diagnosis, management, and treatment planning for individuals with or at risk of developing Dilated Cardiomyopathy type 1Z. It can also provide essential information for family members regarding their risk of inheriting the condition.
DNA Labs UAE is equipped with state-of-the-art facilities and employs highly skilled professionals to conduct this test, ensuring accurate and reliable results. The test is recommended for individuals with a family history of DCM or those exhibiting symptoms related to heart muscle dysfunction. Early detection through the TNNC1 Gene Cardiomyopathy Dilated Type 1Z Genetic Test can significantly impact the management and prognosis of the condition, offering a better quality of life for affected individuals.
The "TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TNNI3 gene that are associated with Dilated Cardiomyopathy (DCM) type 2A. This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to heart enlargement and impaired systolic function. The TNNI3 gene plays a crucial role in the heart's muscle contraction mechanism, and mutations in this gene can disrupt heart function, contributing to the development of DCM.
This genetic test is essential for individuals with a family history of DCM or those who have been clinically diagnosed with heart muscle disorders, as it can provide a definitive diagnosis of the condition. Early detection through genetic testing enables targeted treatment strategies, potentially improving outcomes and quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test is 4400 AED. This price reflects the comprehensive analysis and the specialized technology required to accurately identify mutations within the TNNI3 gene. Individuals undergoing this test can expect a reliable service backed by the expertise of DNA Labs UAE, offering crucial insights into their genetic health and aiding in the management of Dilated Cardiomyopathy.
The GATAD1 Gene Cardiomyopathy Dilated Type 2B Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GATAD1 gene, which have been associated with Dilated Cardiomyopathy (DCM) type 2B. This condition is characterized by the dilation and impaired contraction of the ventricles, which can lead to heart failure and arrhythmias. Early detection through genetic testing is crucial for the management and treatment of the condition, allowing for personalized medical interventions and lifestyle adjustments.
The test is priced at 4400 AED and involves a simple, non-invasive procedure where a sample of the patient's DNA is analyzed for specific mutations in the GATAD1 gene. The results from this test can provide valuable insights into the patient's genetic predisposition to DCM type 2B, enabling healthcare providers to develop a tailored approach to care, including monitoring for heart health, recommending lifestyle changes, and potentially initiating preventive treatments to mitigate the risk of heart failure and other complications associated with the condition.
DNA Labs UAE, where the test is conducted, is equipped with state-of-the-art technology and staffed by experts in genetic diagnostics, ensuring accurate and reliable results. This test represents a critical step forward in the personalized medicine approach to treating and managing cardiomyopathies, offering hope and improved outcomes for patients at risk of this challenging condition.
The "DMD Gene Cardiomyopathy Dilated Type 3B Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the DMD gene, which are associated with dilated cardiomyopathy type 3B. This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to enlargement of the heart's chambers and weakened heart muscle. The test is particularly crucial for individuals with a family history of cardiomyopathy or those showing symptoms of heart muscle disease, as early detection can significantly impact management and treatment strategies. The test cost is set at 4400 AED, reflecting the advanced genetic analysis involved in identifying the specific mutations within the DMD gene. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of cardiomyopathy, enabling personalized treatment plans and potentially improving patient outcomes.
The "MAP2K1 Gene Cardiofaciocutaneous Syndrome Type 3 Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the MAP2K1 gene, which are associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3). This rare genetic disorder is characterized by distinctive facial features, heart defects, skin abnormalities, and developmental delays. The test is crucial for early diagnosis and management of the syndrome, providing vital information for personalized treatment plans and family planning.
Performed through a simple blood sample or cheek swab, the test examines the MAP2K1 gene for specific mutations known to cause CFC3. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these genetic variations. DNA Labs UAE, known for its state-of-the-art facilities and highly qualified geneticists, ensures a reliable and efficient testing process, making it a trusted choice for patients and healthcare providers seeking comprehensive genetic analysis for Cardiofaciocutaneous Syndrome Type 3.
The MAP2K2 gene plays a critical role in the RAS/MAPK signaling pathway, which is essential for cell division, differentiation, and apoptosis. Mutations in this gene are associated with Cardiofaciocutaneous Syndrome Type 4 (CFC4), a rare genetic condition characterized by distinctive facial features, heart defects, skin abnormalities, and developmental delays.
To diagnose this condition, a genetic test focusing on the MAP2K2 gene can be conducted. This test involves analyzing the patient's DNA to identify mutations in the MAP2K2 gene that are indicative of CFC4. It is a crucial step for families seeking answers to developmental and health concerns related to the syndrome.
At DNA Labs UAE, the test for identifying mutations in the MAP2K2 gene associated with Cardiofaciocutaneous Syndrome Type 4 is available. The cost of the test is 4400 AED. This facility employs advanced genetic testing technologies to provide accurate and reliable results, helping in the diagnosis and management of the condition. Early diagnosis through this test can significantly aid in the implementation of appropriate care and interventions, improving the quality of life for individuals with CFC4.
The MT-ATP8 gene plays a crucial role in the mitochondrial function of producing energy within cells. Mutations in this gene can lead to a variety of mitochondrial disorders, including cardiomyopathy, specifically apical hypertrophic cardiomyopathy, and neuropathy. Apical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy where the heart muscle thickens at the apex of the heart, potentially leading to heart failure and arrhythmias. Neuropathy related to MT-ATP8 mutations involves damage to the peripheral nerves, resulting in weakness, pain, and sensory issues.
To diagnose conditions related to MT-ATP8 mutations, genetic testing is essential. DNA Labs UAE offers a specialized genetic test targeting the MT-ATP8 gene to identify mutations that could lead to cardiomyopathy and neuropathy. This test is crucial for individuals with a family history of mitochondrial disorders or those exhibiting symptoms of the mentioned conditions, as it can provide a definitive diagnosis and guide treatment options.
The cost of the MT-ATP8 related genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the MT-ATP8 gene. Results from this test can help healthcare providers develop a personalized treatment plan for affected individuals, potentially improving their quality of life and managing symptoms more effectively.
The "MYBPC3 Gene Cardiomyopathy Dilated Genetic Test" is a specialized diagnostic assessment conducted at DNA Labs UAE, aimed at identifying mutations in the MYBPC3 gene, which have been associated with the development of dilated cardiomyopathy (DCM). Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's ventricles, leading to impaired cardiac function. The MYBPC3 gene plays a crucial role in the structure and function of the heart muscle, and mutations in this gene can disrupt heart muscle function, contributing to the development of DCM.
This genetic test is essential for individuals with a family history of dilated cardiomyopathy or those who exhibit symptoms of the condition, as it can provide definitive genetic evidence of the disease's presence. Early detection through genetic testing allows for timely intervention and management strategies to delay the progression of the disease, improve quality of life, and reduce the risk of complications such as heart failure or arrhythmias.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory at DNA Labs UAE. The process is designed to be comprehensive and accurate, ensuring individuals receive critical information about their genetic predisposition to dilated cardiomyopathy. Upon completion of the test, genetic counselors at DNA Labs UAE can provide guidance and support to individuals and their families, helping them understand the results and implications for their health and lifestyle choices.
The CRYAB Gene Cardiomyopathy Dilated Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the CRYAB gene, which are associated with the development of Dilated Cardiomyopathy (DCM) type 1. Dilated Cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's ventricles, leading to impaired blood pumping efficiency. The CRYAB gene plays a crucial role in encoding the alpha-B crystallin protein, which is significant for the proper functioning and structural integrity of cardiac muscle cells.
This genetic test is particularly important for individuals with a family history of DCM or those exhibiting symptoms suggestive of cardiomyopathy, as it can provide crucial insights into the genetic underpinnings of their condition. Early detection through genetic testing enables more personalized and effective management strategies, potentially improving outcomes and quality of life for affected individuals.
The test is conducted using a blood sample from the patient, which is then analyzed using advanced genetic sequencing techniques to detect any mutations in the CRYAB gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the patient's genetic risk factors for developing Dilated Cardiomyopathy Type 1.
DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced geneticists and medical professionals, ensuring high-quality testing and reliable results. By opting for the CRYAB Gene Cardiomyopathy Dilated Type 1 Genetic Test, patients and healthcare providers can take a significant step towards understanding and managing the risks associated with this serious cardiac condition.
